Comperative Cost-Effectiveness of Anticoagulation with Bivalirudin or Heparin With or Without Glycoprotein IIb/IIIa-Receptor Inhibitor in Patients Undergoing Percutaneous Coronary Intervention in Sweden: A Decision- Analytic Model